DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs
DARPA-SN-26-77 The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued Special Notice DARPA-SN-26-77 to announce forthcoming areas of interest for the Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) program. As part of DARPA’s broader mission to accelerate breakthrough technologies for national security, this initiative aims to address one of […]
DARPA’s RAPIID Program to Transform Trauma Care with Shelf-Stable Blood Analogs Read More »











